Go Pro

Andrew William Robert Bell Sells 703 Shares of Kinaxis (TSE:KXS) Stock

Kinaxis logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Kinaxis insider Andrew William Robert Bell sold 703 shares at an average price of C$171.46, generating C$120,536.38. His remaining stake fell by 32.58% to 1,455 shares.
  • Kinaxis shares rose 2.8% to C$177.17, while the company reported quarterly EPS of C$1.08 and revenue of C$230.64 million.
  • Analysts remain bullish, with seven Buy ratings and a consensus price target of C$203.12; several firms recently raised their targets to C$205–C$210.
  • MarketBeat previews top five stocks to own in September.

Kinaxis Inc. (TSE:KXS - Get Free Report) insider Andrew William Robert Bell sold 703 shares of the company's stock in a transaction on Friday, August 14th. The stock was sold at an average price of C$171.46, for a total value of C$120,536.38. Following the sale, the insider owned 1,455 shares of the company's stock, valued at approximately C$249,474.30. This represents a 32.58% decrease in their position.

Kinaxis Stock Up 2.8%

Shares of TSE:KXS traded up C$4.83 on Wednesday, reaching C$177.17. The company had a trading volume of 38,605 shares, compared to its average volume of 120,983. Kinaxis Inc. has a 52-week low of C$117.22 and a 52-week high of C$196.63. The firm's 50 day simple moving average is C$158.89 and its 200-day simple moving average is C$146.23. The firm has a market capitalization of C$4.82 billion, a PE ratio of 57.90, a PEG ratio of 3.60 and a beta of 0.76. The company has a current ratio of 1.88, a quick ratio of 2.29 and a debt-to-equity ratio of 11.14.

Kinaxis (TSE:KXS - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported C$1.08 EPS for the quarter. The firm had revenue of C$230.64 million during the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%. As a group, analysts expect that Kinaxis Inc. will post 4.2526231 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on KXS shares. BMO Capital Markets boosted their target price on shares of Kinaxis from C$195.00 to C$200.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. National Bank Financial raised their price target on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an "outperform" rating in a report on Friday, August 7th. Canadian Imperial Bank of Commerce lifted their price objective on shares of Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. Stifel Nicolaus reduced their price objective on shares of Kinaxis from C$245.00 to C$200.00 and set a "buy" rating for the company in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their target price on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an "outperform" rating in a research report on Friday, May 8th. Seven research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of C$203.12.

View Our Latest Research Report on Kinaxis

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain - from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption.

Featured Articles

Insider Buying and Selling by Quarter for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines